Bosh sahifaNECLIFE • NSE
add
Nectar Lifesciences Ltd
Yopilish kursi
32,50 ₹
Kunlik diapazon
31,87 ₹ - 33,00 ₹
Yillik diapazon
26,15 ₹ - 56,50 ₹
Bozor kapitalizatsiyasi
7,50 mlrd INR
Oʻrtacha hajm
687,77 ming
Narx/foyda
69,24
Dividend daromadliligi
-
Asosiy maydon
NSE
Bozor yangiliklari
Yahoo Finance
15 daqiqa oldin
OneMedNet Announces Receipt of Nasdaq Notice Regarding Delayed Form 10-Q
8,59%
0,48%
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (INR) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 4,28 mlrd | 7,52% |
Joriy xarajat | 1,04 mlrd | 5,51% |
Sof foyda | 55,99 mln | 451,45% |
Sof foyda marjasi | 1,31 | 403,85% |
Har bir ulushga tushum | — | — |
EBITDA | 432,89 mln | 61,08% |
Amaldagi soliq stavkasi | 35,39% | — |
Balans
Jami aktivlari
Jami passivlari
| (INR) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 187,35 mln | -7,94% |
Jami aktivlari | 21,83 mlrd | 1,89% |
Jami passivlari | 11,05 mlrd | 2,80% |
Umumiy kapital | 10,78 mlrd | — |
Tarqatilgan aksiyalar | 223,96 mln | — |
Narxi/balansdagi bahosi | 0,68 | — |
Aktivlardan daromad | — | — |
Kapitaldan daromad | 4,07% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (INR) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 55,99 mln | 451,45% |
Operatsiyalardan naqd pul | — | — |
Sarmoyadan naqd pul | — | — |
Moliyadan naqd pul | — | — |
Naqd pulning sof oʻzgarishi | — | — |
Boʻsh pul | — | — |
Haqida
Nectar Lifesciences Limited is a pharmaceutical company in India that manufactures generic drug products. The company has global leadership in several oral and sterile cephalosporin drugs, and has cGMP facilities along with those approved by the European Union and Japan. Wikipedia
Tashkil etilgan
1995
Bosh ofis
Sayt
Xodimlar soni
1 686
